Logo image
Back
Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
Journal article   Open access   Peer reviewed

Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy

Tido von Schoen-Angerer, Raj Manchanda, Iva Lloyd, Jon Wardle, Janka Szöke, Iracema Benevides, Natalia Aldana Martinez, Festus Tolo, Ton Nicolai, Cristal Skaling-Klopstock, …
BMJ global health, Vol.8, e013150
02/12/2023
DOI: https://doi.org/10.1136/bmjgh-2023-013150
pdf
Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy279.07 kBDownloadView
Published (Version of record)CC BY-NC V4.0,  Open Access
url
Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategyView
Published (Version of record)CC BY-NC V4.0,  Open

Related links

Metrics

4 File views/ downloads
31 Record Views

Abstract

Acupuncture Alternative medicine Ayurvedic medicine Chinese medicine Collaboration Herbal medicine Integrative medicine Medical personnel Multiculturalism & pluralism Professionals Quality control Regulation Research centers Stakeholders
As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy.

Details

Logo image